Demystifying the immune system with the help of AI-ML
Immunotherapy drugs continue to gain momentum across a growing range of disease areas with blockbusters such as MSD's Keytruda (pembrolizumab) …
Immunotherapy drugs continue to gain momentum across a growing range of disease areas with blockbusters such as MSD's Keytruda (pembrolizumab) …
Roche’s CEO Thomas Schinecker said the drugmaker is continuing talks with the US government over drug pricing reforms, as President …
GlobalData’s Venture Capital Investment Trends In Pharma – Q3 2025 report revealed that the biotech industry witnessed a 70.9% increase …
Takeda and Innovent Biologics have signed a deal worth up to $11.4bn following its bid to focus on bispecifics and …
With diabetes diagnoses growing globally, remote monitoring technologies developed in Scotland are now providing essential solutions for managing the condition. The …
Ipsen is set to purchase all issued and outstanding shares of the French biotechnology company ImCheck Therapeutics, which specialises in …
Early-stage equity raises for biotechs surged by 71% in Q3 2025, suggesting the funding freeze that has gripped the industry …
Alkermes has agreed to acquire Avadel Pharmaceuticals for up to $20 per share in cash, valuing Avadel at $2.1bn. The acquisition …
The growing friction between the US and China has serious consequences for the supplies of high-potency active pharmaceutical ingredients (HPAPIs), …
ADCs are precision medicines that hitch a cell-killing drug (the “payload”) to an antibody via a chemical “linker”. The antibody …
Galapagos NV is winding down its cell and gene therapy (CGT) division after an unsuccessful attempt to sell the unit, …
On Saturday 19 October 2025, at the European Society for Medical Oncology (ESMO), held in Berlin, Germany, Hengrui presented results …
Novo Nordisk has announced that seven members of its board of directors will stand down from their roles. This includes board …
This long-awaited guideline will revolutionise clinical trial management across life sciences, giving CGT developers a regulatory framework that finally matches …
Ventus Therapeutics has entered a multi-year partnership with Roche’s Genentech for the discovery and optimisation of new small-molecule medicines, utilising …